Page last updated: 2024-11-10

3-amino-1,4-dimethyl-5h-pyrido(4,3-b)indole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5284474
CHEBI ID82376
SCHEMBL ID894928
MeSH IDM0071323

Synonyms (33)

Synonym
tryptophan p1
1,4-dimethyl-9h-pyrido(4,3-b)indol-3-amine
brn 0653052
trp-1
ccris 1414
5h-pyrido(4,3-b)indol-3-amine, 1,4-dimethyl-
5h-pyrido(4,3-b)indole, 3-amino-1,4-dimethyl-
tryptophan-p-1
trytophan pyrolysate 1
3-amino-1,4-dimethyl-5h-pyrido(4,3-b)indole
3-amino-1,4-dimethyl-gamma-carboline
trp-p-1
1,4-dimethyl-5h-pyrido[4,3-b]indol-3-amine
C19306
62450-06-0
3-amino-1,4-dimethyl-5h-pyrido[4,3-b]indole
lah2r5z22d ,
unii-lah2r5z22d
trp-p-1 [iarc]
trp-p 1
tryptophan p 1
1,4-dimethyl-5h-pyrido(4,3-b)indol-3-amine
3-amino-1,4-dimethyl-.gamma.-carboline
SCHEMBL894928
CHEBI:82376
DTXSID0043767 ,
5h-pyrido[4,3-b]indol-3-amine, 1,4-dimethyl-
1,4-dimethyl-5h-pyrido[4,3-b]indol-3-amine, 9ci
3-amino-1,4-dimethyl-g-carboline
trp-p1
Q27155906
dtxcid8023767
trp-p-1 (iarc)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" While the tryptophan pyrolysis product 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) and the mycotoxin sterigmatocystin were highly toxic to the cultures at moderate concentration (1 microgram/ml), the potency of each agent was increased > or = 10-fold in the presence of TCDD."( 2,3,7,8-Tetrachlorodibenzo-p-dioxin sensitization of cultured human epidermal cells to carcinogenic heterocyclic amine toxicity.
deGraffenried, LA; Rice, RH; Walsh, AA, 1995
)
0.29
" 6-Nitrochrysene, a known direct-acting mutagen in bacteria, was highly toxic to the rat but not to the human cells."( Cytotoxicity and keratinocyte microsome-mediated mutagenic activation of carcinogens in cultured epidermal cells.
Chun, HS; Kado, NY; Kuzmicky, PA; Rice, RH; Rucoba, L, 2000
)
0.31

Bioavailability

ExcerptReferenceRelevance
" Finally, we demonstrated that the biological activity of Trp-P-1 and Trp-P-2 is strictly dependent on the presence of the mutagen in a free (unbound with methylxanthine) form, suggesting that mutagen sequestration in stacking heterocomplexes with methylxanthines can decrease its bioavailability and diminish its biological effects."( Caffeine and other methylxanthines as interceptors of food-borne aromatic mutagens: inhibition of Trp-P-1 and Trp-P-2 mutagenic activity.
Gołuński, G; Kaźmierkiewicz, R; Piosik, J; Woziwodzka, A; Wyrzykowski, D, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
"The present investigation describes a method for the detection of minute amounts of 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1), a carcinogenic tryptophan pyrolysate, bound to the hemoglobin of erythrocytes and plasma from rabbits dosed orally with the dietary carcinogen."( Exposure level monitor of 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, a dietary carcinogen, in rabbits.
Kanai, Y; Manabe, S; Wada, O, 1989
)
0.28
" Studies with the intact lung and with isolated lung cells show that carcinogen metabolism and pharmacokinetics depend both on the route of exposure and dosage and on the distribution of specific enzymes."( Effects of induction and age-dependent enzyme expression on lung bioavailability, metabolism, and DNA binding of urban air particulate-absorbed benzo[a]pyrene, 2-nitrofluorene, and 3-amino-1,4-dimethyl-5H-pyridol-(4,3)-indole.
Gøtze, JP; Lindeskog, P; Törnquist, CS, 1994
)
0.29
" On the other hand, concentrations in the micromolar range that are reached in high dosage animal experiments with HA may well influence cytochrome activity and, thus, influence the experimental outcome of these studies."( Modulation of cytochrome P450 1A1 by food-derived heterocyclic aromatic amines.
Hümmerich, J; Pfau, W; Zohm, C, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridoindole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (161)

TimeframeStudies, This Drug (%)All Drugs %
pre-199045 (27.95)18.7374
1990's69 (42.86)18.2507
2000's40 (24.84)29.6817
2010's6 (3.73)24.3611
2020's1 (0.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.24 (24.57)
Research Supply Index5.14 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.18%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other167 (98.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]